Advisory Opinions On Supplement Ad Claims Infeasible, FTC Finds
This article was originally published in The Tan Sheet
Executive Summary
Providing companies with advisory opinions clarifying Federal Trade Commission positions on "competent and reliable scientific evidence" standards for dietary supplement ad claims may not be feasible due to human resource concerns and previous rulings, the commission states.
You may also be interested in...
FTC Should Send Warning Letters For Potentially Misleading Claims – Petition
The Federal Trade Commission should use warning letters when contested health benefit claims are "at worst, only potentially misleading," according to a petition for rulemaking submitted to FTC April 15
FTC Criteria For Structure/Function Claim Ad Evaluation Sought By Marketers
The Federal Trade Commission either should issue advisory opinions concerning dietary supplement structure/function claim advertising or define the criteria it uses in deciding whether such ads satisfy the "competent and reliable scientific evidence" standard, four supplement marketers say in a petition for rulemaking filed with FTC Dec. 21.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC